These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10346922)

  • 1. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
    Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
    J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as platelet aggregation inhibitors. 2. Optimization by quantitative structure-activity relationships.
    Campillo N; Goya P; Páez JA
    J Med Chem; 1999 Aug; 42(17):3279-88. PubMed ID: 10464014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Nitrosoimino-3,6-dihydro-2H-1,3,4-thiadiazines with antiplatelet and antithrombotic properties.
    Rehse K; Brümmer U; Unsöld E
    Pharmazie; 1998 Dec; 53(12):820-4. PubMed ID: 9879566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
    Francotte P; Tullio Pd; Goffin E; Dintilhac G; Graindorge E; Fraikin P; Lestage P; Danober L; Thomas JY; Caignard DH; Pirotte B
    J Med Chem; 2007 Jun; 50(13):3153-7. PubMed ID: 17552506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluation.
    Pirotte B; Ouedraogo R; de Tullio P; Khelili S; Somers F; Boverie S; Dupont L; Fontaine J; Damas J; Lebrun P
    J Med Chem; 2000 Apr; 43(8):1456-66. PubMed ID: 10780901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
    Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
    Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
    Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
    J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of new 1,3,4-thiadiazines on platelet aggregation in vitro and ex vivo].
    Logvinova OS; Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perova NM; Rusinov VL
    Eksp Klin Farmakol; 2010 Aug; 73(8):21-5. PubMed ID: 20919553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antiaggregant action of 2-morpholino-5-(thienyl-2)-6-H-1,3,4-thiadiazine in in vitro and ex vivo experiments].
    Logvinova IuS; Makarov VA; Chupakhin ON; Sidorova LP; Perova NM; Rusinov VL
    Eksp Klin Farmakol; 2013; 76(2):13-6. PubMed ID: 23631277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators.
    Francotte P; de Tullio P; Podona T; Diouf O; Fraikin P; Lestage P; Danober L; Thomas JY; Caignard DH; Pirotte B
    Bioorg Med Chem; 2008 Dec; 16(23):9948-56. PubMed ID: 18980844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel bronchodilators: synthesis, transamination reactions, and pharmacology of a series of pyrazino[2,3-c][1,2,6]thiadiazine 2, 2-dioxides.
    Campillo N; García C; Goya P; Alkorta I; Páez JA
    J Med Chem; 2000 Nov; 43(22):4219-27. PubMed ID: 11063618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
    Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
    Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antiplatelet and in silico evaluations of novel N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
    Jordão AK; Ferreira VF; Lima ES; de Souza MC; Carlos EC; Castro HC; Geraldo RB; Rodrigues CR; Almeida MC; Cunha AC
    Bioorg Med Chem; 2009 May; 17(10):3713-9. PubMed ID: 19380229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of 2,3-dialkylindoles, "in vitro" inhibitors of thrombin-induced platelet aggregation.
    Arcari M; Aveta R; Brandt A; Cecchetelli L; Corsi GB; Solinas F
    Farmaco; 1992 Apr; 47(4):405-25. PubMed ID: 1388590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships.
    Pirotte B; Podona T; Diouf O; de Tullio P; Lebrun P; Dupont L; Somers F; Delarge J; Morain P; Lestage P; Lepagnol J; Spedding M
    J Med Chem; 1998 Jul; 41(16):2946-59. PubMed ID: 9685234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
    Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
    Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
    Huang WH; Lee AR; Chien PY; Chou TC
    J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.